Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy
T cell function can be compromised during chronic infections or through continuous exposure to tumor antigens by the action of immune checkpoint receptors, such as programmed cell death protein 1 (PD-1). Systemic administration of blocking antibodies against the PD-1 pathway can restore T cell funct...
Main Authors: | Zhang, C, Peng, Y, Hublitz, P, Zhang, H, Dong, T |
---|---|
Format: | Journal article |
Published: |
Springer Nature
2018
|
Similar Items
-
Microbial synthesis of Prussian blue for potentiating checkpoint blockade immunotherapy
by: Wang, Dongdong, et al.
Published: (2023) -
Antigen presenting cells in cancer immunity and mediation of immune checkpoint blockade
by: Wang, Cassia, et al.
Published: (2024) -
Generation and enrichment of antigen-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
by: Oelke, M, et al.
Published: (2000) -
New approaches to treating cancer using immune-checkpoint blockade
by: Fellermeyer, M
Published: (2023) -
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma
by: Taylor, CA, et al.
Published: (2022)